Kornit Digital's Daniel Gazit sells 552 shares
The shares sold were tied to RSUs granted in 2022 and 2023, with the latter grant scheduled to vest fully by March 9, 2027.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Kornit Digital Ltd. Chief Product Officer Daniel Gazit sold 552 ordinary shares on October 9, 2026, in two reported transactions of 436 and 116 shares. The reported weighted average sale price was $19.01 per share, and the transactions were made pursuant to a Rule 10b5-1 plan. The Form 4 also lists 7,000 options to buy ordinary shares, with a $105.06 exercise price and a January 31, 2032 expiration date.
Insider Trade Summary 10b5-1
Net Seller: 552 shares
Net Sell
6 txns
Insider
Gazit Daniel
Role
Chief Product Officer
Sold
552 shs ($10K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares F1, F2 | 436 | $19.01 | $8K |
| Sale | Ordinary Shares F1, F3 | 116 | $19.01 | $2K |
| holding | Stock Option (right to buy) F4 | -- | -- | -- |
| holding | Ordinary Shares F4 | -- | -- | -- |
| holding | Ordinary Shares F4, F5 | -- | -- | -- |
| holding | Ordinary Shares F4, F6 | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 32,217 shares (Direct);
Stock Option (right to buy) — 7,000 contracts (Direct)
Footnotes (6)
- F1. The price reported represents a weighted average price. The Reporting Person undertakes to provide to the SEC staff, upon request, full information regarding the number of shares and prices at which the transactions were effected.
- F2. The ordinary shares reported in this row consist of shares that were issued upon settlement of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person on September 19, 2022 and that have fully vested and settled for underlying ordinary shares (which reflect a reduced quantity relative to the originally granted amount of 4,385 RSUs due to sales of underlying shares to date).
- F3. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 9, 2023 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the original 10,188 RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the original 10,188 RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row (which reflects a reduced number relative to the originally granted amount due to sales of underlying shares to date) will be fully vested and settled by the four-year anniversary of that grant date (March 9, 2027).
- F4. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F5. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 19, 2024 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled by the four-year anniversary of that grant date (March 19, 2028).
- F6. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 13, 2025 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled by the four-year anniversary of that grant date (March 13, 2029).
Key Figures
Shares sold: 552 shares
Reported sale transaction: 436 shares
Reported sale transaction: 116 shares
+4 more
7 metrics
Shares sold
552 shares
October 9, 2026
Reported sale transaction
436 shares
October 9, 2026
Reported sale transaction
116 shares
October 9, 2026
Weighted average sale price
$19.01 per share
October 9, 2026
Options to buy ordinary shares
7,000 shares
Direct holding reported
Option exercise price
$105.06 per share
Options to buy ordinary shares
Option expiration
January 31, 2032
Options to buy ordinary shares
Key Terms
weighted average price, restricted share units ("RSUs"), Stock Option (right to buy)
3 terms
weighted average price financial
"The price reported represents a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (right to buy) financial
"Stock Option (right to buy)"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock options did Daniel Gazit report for KRNT?
He reported options to buy 7,000 ordinary shares at an exercise price of $105.06 per share, expiring January 31, 2032.
AI-generated analysis. How Rhea-AI works. Not financial advice.
